Page last updated: 2024-10-28

phenelzine and Cancer of Prostate

phenelzine has been researched along with Cancer of Prostate in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Research Excerpts

ExcerptRelevanceReference
"Monoamine oxidase A (MAOA) influences prostate cancer growth and metastasis in pre-clinical models."3.01Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer. ( Agus, DB; Castellanos, O; Dorff, TB; Gilmore, P; Gross, ME; Pinski, JK; Quinn, DI; Shih, JC, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gross, ME1
Agus, DB1
Dorff, TB1
Pinski, JK1
Quinn, DI1
Castellanos, O1
Gilmore, P1
Shih, JC1
Stone, L1

Trials

1 trial available for phenelzine and Cancer of Prostate

ArticleYear
Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
    Prostate cancer and prostatic diseases, 2021, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Disease-Free Survival; Dose-Response Relationship, Drug; Dr

2021

Other Studies

1 other study available for phenelzine and Cancer of Prostate

ArticleYear
MAOA inhibitor phenelzine efficacious in recurrent prostate cancer.
    Nature reviews. Urology, 2020, Volume: 17, Issue:4

    Topics: Humans; Male; Monoamine Oxidase Inhibitors; Neoplasm Recurrence, Local; Phenelzine; Prostatic Neopla

2020